Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 28 of 28 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/24/03
End: 10/07/09
Due: 10/07/10
Phase: N/A
Priority: Normal
Start: 08/17/22
End: 08/27/23
Due: 08/27/24
Phase: N/A
Priority: Normal
Start: 06/12/12
End: 04/24/13
Due: 04/24/14
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant | NCT02118896 | Astellas Pharma Europe Ltd. | user2@example.com | None | 2003-02-24 | 2009-10-07 | 2010-10-07 | - | - | 2025-07-14 |
| A Survey About Trade-offs When Choosing Menopause Treatments | NCT05300568 | Astellas Pharma Europe Ltd. | user2@example.com | None | 2022-08-17 | 2023-08-27 | 2024-08-27 | - | - | 2025-07-14 |
| A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. | NCT01638000 | Astellas Pharma Europe Ltd. | user2@example.com | None | 2012-06-12 | 2013-04-24 | 2014-04-24 | - | - | 2025-07-14 |